RESUMO
The simultaneous presence of intracellular neurofibrillary tangles (NFT) and extracellular senile plaques in Alzheimer's disease (AD) suggests that the two lesions could be synergistically interrelated. However, although the main protein components of NFT and senile plaques, tau (tau) and amyloid beta-protein, respectively, are well characterized, the molecular mechanisms responsible for their deposition in lesions are unknown. We demonstrate, using four independent techniques, that tau directly interacts with a conformation-dependent domain of the amyloid beta-protein precursor (beta PP) encompassing residues beta PP714-723. The putative tau-binding domain includes beta PP717 mutation sites that are associated with familial forms of AD. Our findings strongly suggest that NFT and senile plaques, often thought of as independent structures, may play a role in each other's formation during the pathogenesis of AD.
Assuntos
Doença de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Encéfalo/metabolismo , Proteínas tau/metabolismo , Doença de Alzheimer/etiologia , Sequência de Aminoácidos , Precursor de Proteína beta-Amiloide/química , Humanos , Immunoblotting , Técnicas Imunoenzimáticas , Imuno-Histoquímica , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/metabolismoRESUMO
AIMS: The literature and teachings instruct that neurones in the adult brain are fully differentiated, quiescent cells that never divide. Somewhat surprisingly, and counter to such dogma, susceptible neurones in Alzheimer disease display an activated cell cycle phenotype. However, whether this leads to a coordinated procession through the cell cycle is unclear, particularly whether neurones enter anaphase and beyond. To begin to address this issue, in this study we sought to determine whether nuclear division occurs in these neurones. METHODS: We examined a series of 101 archived, routinely stained hippocampal sections collected at post mortem for neuropathological evaluation for evidence of neuronal binucleation. RESULTS: We report for the first time, binucleated neurones within the hippocampus in cases of Alzheimer disease but not in control cases (P < 0.05). CONCLUSIONS: While a relatively rare event, occurring once every 20,000 neurones, this morphological evidence that neuronal cells within the cortical regions of the adult human brain in Alzheimer disease contain two nuclei supports the hypothesis that neuronal cells can re-enter into a coordinated cell cycle that culminates in nuclear division.
Assuntos
Doença de Alzheimer/patologia , Hipocampo/patologia , Neurônios/patologia , Neurônios/ultraestrutura , Idoso , Idoso de 80 Anos ou mais , Autopsia , Feminino , Humanos , MasculinoRESUMO
The finding that oxidative damage, including that to nucleic acids, in Alzheimer's disease is primarily limited to the cytoplasm of susceptible neuronal populations suggests that mitochondrial abnormalities might be part of the spectrum of chronic oxidative stress of Alzheimer's disease. In this study, we used in situ hybridization to mitochondrial DNA (mtDNA), immunocytochemistry of cytochrome oxidase, and morphometry of electron micrographs of biopsy specimens to determine whether there are mitochondrial abnormalities in Alzheimer's disease and their relationship to oxidative damage marked by 8-hydroxyguanosine and nitrotyrosine. We found that the same neurons showing increased oxidative damage in Alzheimer's disease have a striking and significant increase in mtDNA and cytochrome oxidase. Surprisingly, much of the mtDNA and cytochrome oxidase is found in the neuronal cytoplasm and in the case of mtDNA, the vacuoles associated with lipofuscin. Morphometric analysis showed that mitochondria are significantly reduced in Alzheimer's disease. The relationship shown here between the site and extent of mitochondrial abnormalities and oxidative damage suggests an intimate and early association between these features in Alzheimer's disease.
Assuntos
Doença de Alzheimer/patologia , Guanosina/análogos & derivados , Mitocôndrias/patologia , Mitocôndrias/ultraestrutura , Estresse Oxidativo , Tirosina/análogos & derivados , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/etiologia , Cerebelo/patologia , Cerebelo/ultraestrutura , Criança , Pré-Escolar , DNA Mitocondrial/metabolismo , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Lobo Frontal/patologia , Lobo Frontal/ultraestrutura , Guanosina/metabolismo , Hipocampo/patologia , Hipocampo/ultraestrutura , Humanos , Imuno-Histoquímica , Hibridização In Situ , Microscopia Eletrônica , Pessoa de Meia-Idade , Mitocôndrias/metabolismo , Neurônios/metabolismo , Neurônios/patologia , Neurônios/ultraestrutura , Lobo Temporal/patologia , Lobo Temporal/ultraestrutura , Tirosina/metabolismoRESUMO
Ku70 (Lupus Ku autoantigen p70) is essential in nonhomologous end joining DNA double-strand break repair, and ku70(-/-) mice age prematurely because of increased genomic instability and DNA damage responses. Previously, we found that Ku70 also inhibits Bax, a key mediator of apoptosis. We hypothesized that Bax-mediated apoptosis would be enhanced in the absence of Ku70 and contribute to premature death observed in ku70(-/-) mice. Here, we show that ku70(-/-) bax(+/-) and ku70(-/-) bax(-/-) mice have better survival, especially in females, than ku70(-/-) mice, even though Bax deficiency did not decrease the incidence of lymphoma observed in a Ku70-null background. Moreover, we found that ku70(-/-) mice develop lung diseases, like emphysema and pulmonary arterial (PA) occlusion, by 3 months of age. These lung abnormalities can trigger secondary health problems such as heart failure that may account for the poor survival of ku70(-/-) mice. Importantly, Bax deficiency appeared to delay the development of emphysema. This study suggests that enhanced Bax activity exacerbates the negative impact of Ku70 deletion. Furthermore, the underlying mechanisms of emphysema and pulmonary hypertension due to PA occlusion are not well understood, and therefore ku70(-/-) and Bax-deficient ku70(-/-) mice may be useful models to study these diseases.
Assuntos
Antígenos Nucleares/genética , Proteínas de Ligação a DNA/genética , Pneumopatias/genética , Linfoma/genética , Proteína X Associada a bcl-2/genética , Animais , Apoptose/genética , Modelos Animais de Doenças , Feminino , Cardiopatias/genética , Cardiopatias/patologia , Humanos , Autoantígeno Ku , Pneumopatias/patologia , Linfoma/patologia , Camundongos , Camundongos KnockoutRESUMO
In an attempt to generate transgenic mice modeling Alzheimer-type amyloidogenesis, the COOH-terminal 103 residue human APP segment was expressed in brain regions known to be vulnerable in AD. Transfected cells overexpressing this transgene were previously shown to develop intracytoplasmic inclusions that were immunoreactive with antibodies to the APP COOH-terminus. Transgenic C57B6/SJL mice produced transgene-coded mRNA in their brains at levels up to sixfold above endogenous APP, most abundantly within cortical and hippocampal pyramidal neurons. Immunocytochemistry with anti-A beta antibodies revealed occasional structures that resembled diffuse amyloid, but which could not be detected on serial sections. Immunolabeling with antibodies to APP regions NH2-terminal to the transgene-coded domain revealed elevated immunoreactivity within perikarya and neurites in regions expressing the highest transgene and endogenous APP mRNA levels, similar to observations previously reported within vulnerable neurons in AD brain. However, subsequent breeding revealed that this phenotype segregated with the B6/SJL background rather than the transgene, thus emphasizing the importance of genetic background to observations of putative AD-type pathology in transgenic animals.
Assuntos
Precursor de Proteína beta-Amiloide/genética , Amiloidose/patologia , Química Encefálica/genética , Doença de Alzheimer/genética , Doença de Alzheimer/patologia , Precursor de Proteína beta-Amiloide/biossíntese , Amiloidose/genética , Amiloidose/metabolismo , Animais , Sequência de Bases , DNA/biossíntese , Humanos , Immunoblotting , Imuno-Histoquímica , Hibridização In Situ , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Microinjeções , Dados de Sequência Molecular , RNA Mensageiro/biossíntese , Especificidade da Espécie , TransgenesRESUMO
Erythrocyte, plasma, and serum antioxidant activities were studied in patients with newly diagnosed and untreated toxic multinodular hyperthyroid goiter and compared to healthy control subjects. Erythrocyte antioxidant enzyme activities, glutathione, malondialdehyde, and ceruloplasmin levels were significantly increased, whereas serum vitamin E, plasma vitamin C, and selenium levels were decreased in hyperthyroid patients compared to control subjects. The findings show that untreated toxic multinodular goiter causes profound alterations in components of the antioxidant system in erythrocytes indicative of increased oxidative stress. Taken together, these data suggest that hyperthyroid patients may benefit from dietary supplements of antioxidants.
Assuntos
Antioxidantes/metabolismo , Eritrócitos/metabolismo , Bócio Nodular/sangue , Bócio Nodular/metabolismo , Hipotireoidismo/sangue , Hipotireoidismo/metabolismo , Adulto , Ácido Ascórbico/sangue , Ceruloplasmina/metabolismo , Eritrócitos/enzimologia , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Bócio Nodular/enzimologia , Humanos , Hipotireoidismo/enzimologia , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Estresse Oxidativo , Radioimunoensaio , Selênio/sangue , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Vitamina E/sangueRESUMO
There is a great deal of evidence that places oxidative stress as a proximal event in the natural history of Alzheimer disease (AD). In addition to increased damage, there are compensatory increases in the levels of free sulfhydryls, glucose-6-phosphate dehydrogenase, and NAD(P)H:quinone oxidoreductase 1. To investigate redox homeostasis further in AD, we analyzed protein disulfide isomerase (PDI), a multifunctional enzyme, which catalyzes the disruption and formation of disulfide bonds. PDI plays a pivotal role in both secreted and cell-surface-associated protein disulfide rearrangement. In this study, we show that PDI specifically localizes to neurons, where there is no substantial increase in AD compared to age-matched controls. These findings indicate that the neurons at risk of death in AD do not show a substantial change in PDI to compensate for the increased sulfhydryls and reductive state found during the disease. This suggests that, despite compensatory reductive changes in AD, the level of PDI is sufficiently high physiologically in neurons to accommodate a more reducing environment.
Assuntos
Doença de Alzheimer/enzimologia , Isomerases de Dissulfetos de Proteínas/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais/metabolismo , Autopsia , Estudos de Casos e Controles , Criança , Pré-Escolar , Densitometria , Dissulfetos , Hipocampo/enzimologia , Humanos , Immunoblotting , Imuno-Histoquímica , Pessoa de Meia-Idade , Neurônios/enzimologia , Estresse OxidativoRESUMO
Neurofibrillary tangles (NFT) are abnormal filamentous inclusions that develop in neurons in Alzheimer disease and other disorders. When neurons die, the neurofibrillary tangles that persist in the extracellular space show ultrastructural and antigenic changes. Both intra- and extracellular NFT have recently been shown to contain heparan sulfate proteoglycans (HSPGs). HSPGs are also present in other amyloid deposits in the brain and in systemic amyloidoses. Basic fibroblast growth factor (bFGF) is a heparin binding growth factor which is involved in angiogenesis and also has neurite promoting activity. We now report that bFGF binds avidly to extracellular NFT. Alz-50, a monoclonal antibody (MAb) to an abnormal form of tau and bFGF binding label mutually exclusive subpopulations of neurofibrillary tangles. bFGF binding is abolished by heparinase or heparitinase treatment and therefore is most likely based on the presence of HSPG. Binding of bFGF is a specific and sensitive morphological method to distinguish intra- from extracellular NFT. As intracellular NFT, which also contain HSPGs, are not labeled by bFGF binding, this finding also suggests that HSPGs are modified when the NFT become extracellular.
Assuntos
Doença de Alzheimer/patologia , Fator 2 de Crescimento de Fibroblastos/metabolismo , Hipocampo/ultraestrutura , Neurofibrilas/metabolismo , Lobo Temporal/ultraestrutura , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/metabolismo , Biomarcadores , Hipocampo/metabolismo , Humanos , Microscopia Eletrônica , Neurofibrilas/ultraestrutura , Lobo Temporal/metabolismoRESUMO
Responses to increased oxidative stress may be the common mechanism responsible for the varied cytopathology of Alzheimer disease (AD). A possible link in support of this hypothesis is that one of the most striking features of AD, the abnormal accumulation of highly phosphorylated tau and neurofilament proteins, may be brought about by extracellular receptor kinase (ERK) whose activation is a common response to oxidative stress. In this study, we demonstrate that activated ERK is specifically increased in the same vulnerable neurons in AD that are the site of oxidative damage and abnormal phosphorylation. These findings suggest that ERK dysregulation, likley resulting from oxidative stress, could play an important role in the increased phosphorylation of cytoskeletal proteins observed in AD.
Assuntos
Doença de Alzheimer/enzimologia , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Neurônios/enzimologia , Estresse Oxidativo/fisiologia , Adulto , Idoso , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Encéfalo/enzimologia , Encéfalo/metabolismo , Encéfalo/patologia , Ativação Enzimática/fisiologia , Humanos , Pessoa de Meia-Idade , Neurônios/metabolismo , Fosforilação , Proteínas tau/metabolismoRESUMO
The neurotrophic activity of beta-amyloid protein (beta-AP) has been suggested to be responsible for the dystrophic neurites that surround beta-AP deposits in senile plaques of Alzheimer disease. The recent finding that neurofibrillary tangles (NFT) that remain as remnants in the extracellular space (E-NFT) after the death of the neuron contain beta-AP, suggested that dystrophic neurites might also be associated with E-NFT. In this study, we use a probe for E-NFT, basic fibroblast growth factor (bFGF)-binding to show that E-NFT do contain dystrophic neurites. Since these neurites contain the amyloid precursor protein whose cleavage can lead to beta-AP, they may also play a role in further beta-AP deposition in the E-NFT.
Assuntos
Doença de Alzheimer/patologia , Espaço Extracelular , Neuritos/ultraestrutura , Emaranhados Neurofibrilares/patologia , Idoso , Peptídeos beta-Amiloides/metabolismo , Humanos , Neuritos/metabolismo , Proteínas tau/metabolismoRESUMO
The extracellular matrix protein heparin sulfate proteoglycans (HSPG) has been found in the neurofibrillary pathology of Alzheimer disease. This study was performed to determine if similar proteoglycans might be present in the fibrillary inclusions of other neurodegenerative diseases. Basic fibroblast growth factor (bFGF) binding to heparinase sensitive sites was used as an assay for HSPGs. We found that the inclusions of Pick and Parkinson diseases as well as progressive supranuclear palsy contained heparinase sensitive bFGF binding sites while the inclusions of diffuse Lewy body disease lacked bFGF binding sites. These findings indicate that HSPG's interactions and possible role in the formation of intraneuronal inclusions are not limited to Alzheimer disease.
Assuntos
Fator 2 de Crescimento de Fibroblastos/metabolismo , Doenças do Sistema Nervoso/metabolismo , Idoso , Idoso de 80 Anos ou mais , Demência/metabolismo , Heparina/análogos & derivados , Heparina/metabolismo , Histocitoquímica , Humanos , Corpos de Lewy/metabolismo , Pessoa de Meia-Idade , Degeneração Neural , Doença de Parkinson/metabolismo , Proteoglicanas/metabolismoRESUMO
In this study, we evaluate the ability of several solvents to solubilize insoluble paired helical filaments (PHF) of Alzheimer disease. Specifically, we use protein extraction and reduction in the volume of insoluble material as quantitative assays to establish solvents of PHF. Using sequential categories of protein solvent to analyze insoluble PHF, only alkali or exhaustive proteolysis are effective in completely solubilizing PHF, while a variety of denaturants are ineffective. Alkali does not affect the phosphorylation state of PHF and complete dephosphorylation of PHF with hydrofluoric acid does not affect PHF solubility. These findings suggest that the 'hyperphosphorylation' of PHF proteins is not responsible for PHF insolubility. However the in vitro glycation of tau generates PHF that are insoluble in SDS and soluble in alkali. These findings suggest that protein crosslinks, including advanced glycation endproduct-derived crosslinks which were recently described in Alzheimer disease, play a major role in effecting PHF insolubility in vivo.
Assuntos
Doença de Alzheimer/metabolismo , Proteínas de Neurofilamentos/análise , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Álcalis , Fracionamento Celular , Reagentes de Ligações Cruzadas/análise , Reagentes de Ligações Cruzadas/metabolismo , Densitometria , Endopeptidases , Formiatos , Produtos Finais de Glicação Avançada/análise , Guanidina , Guanidinas , Hemostáticos , Humanos , Immunoblotting , Microscopia Eletrônica , Pessoa de Meia-Idade , Proteínas de Neurofilamentos/metabolismo , Proteínas de Neurofilamentos/ultraestrutura , Fosforilação , Desnaturação Proteica , Dodecilsulfato de Sódio , Solubilidade , UreiaRESUMO
A role for altered iron metabolism in the pathogenesis of Alzheimer's disease has been suggested by several reports associating the cardinal neuropathologic lesions with markers of free radical-induced damage and redox-active iron. We hypothesized that the abnormal distribution of iron in Alzheimer brain might result from alterations in iron regulatory proteins (IRP) such as IRP-1 and IRP-2, the main control elements of cellular iron homeostasis. Here, we report that while IRP-1 is present at similar levels in both Alzheimer and control brain tissue, IRP-2 shows striking differences and is associated with intraneuronal lesions, including neurofibrillary tangles, senile plaque neurites and neuropil threads. Since IRP-2 colocalizes with redox-active iron, our results suggest that alterations in IRP-2 might be directly linked to impaired iron homeostasis in Alzheimer's disease.
Assuntos
Doença de Alzheimer/metabolismo , Metabolismo Energético/fisiologia , Proteínas Ferro-Enxofre/análise , Proteínas do Tecido Nervoso/análise , Estresse Oxidativo/fisiologia , Proteínas de Ligação a RNA/análise , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Homeostase , Humanos , Imuno-Histoquímica , Proteína 1 Reguladora do Ferro , Proteína 2 Reguladora do Ferro , Proteínas Reguladoras de Ferro , Pessoa de Meia-Idade , OxirreduçãoRESUMO
In this study, we found that neuropil threads of Alzheimer disease, rather than being continuous filaments along cell processes, show multiple interruptions. They are segmental in nature and therefore appear as striations rather than continuous filaments along the length of the neurite. Neuritic striation is not an artifact of section thickness since the majority of abnormal filament accumulations are extremely short. The dominance of short striations demonstrates that argyrophilic grains, rather than being distinct structures, simply represent a short variant of striation and that longer striations are arbitrarily considered neuropil threads. Ultrastructural examination showed that the intervals between striations lack a cytoskeleton. We suggest that neuritic striations may interrupt the microtubule system functionally blocking fast neuritic transport as well as playing a role in loss of neuronal connectivity.
Assuntos
Doença de Alzheimer/patologia , Neuritos/patologia , Emaranhados Neurofibrilares/patologia , Neurópilo/patologia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/metabolismo , Transporte Axonal/fisiologia , Humanos , Microscopia Eletrônica , Microtúbulos/metabolismo , Pessoa de Meia-Idade , Neuritos/metabolismo , Neuritos/ultraestrutura , Emaranhados Neurofibrilares/ultraestrutura , Neurônios/metabolismo , Neurônios/patologia , Neurônios/ultraestrutura , Sinapses/metabolismo , Sinapses/patologiaRESUMO
In cerebral amyloid angiopathy, the amyloid-beta (A beta) deposits lie primarily in the tunica media suggesting that smooth muscle cells play an important role in A beta deposition. To define this role, we conducted an immunocytochemical study of brain tissue from cases of Alzheimer disease with extensive cerebral amyloid angiopathy and cerebral hemorrhage. Antibodies specific to recombinant beta protein precursor (beta PP) and synthetic peptides homologous to various beta PP sequences from residue 18 to 689 of beta PP695 were used. Antibodies to actin, tropomyosin, alpha-actinin or desmin were used to label muscle cells. Antibodies to A beta sequences intensely recognized the extracellular amyloid deposit. Antibodies raised against beta PP sequences other than the A beta domain recognized smooth muscle cells. beta PP-immunoreactivity was reduced in regions of A beta deposits, since no muscle cells were recognized by cytoskeletal markers or observed ultrastructurally. In order to assess why A beta is deposited in the tunica media, we used biotin-labelled beta PP to determine if beta PP can be locally retained. We found beta PP bound to the tunica media of vessels but not other brain elements. These findings suggest A beta in blood vessels derives from degenerating beta PP-containing smooth muscle cells.
Assuntos
Doença de Alzheimer/patologia , Angiopatia Amiloide Cerebral/patologia , Córtex Cerebral/irrigação sanguínea , Músculo Liso Vascular/patologia , Actinina/análise , Actinas/análise , Idoso , Idoso de 80 Anos ou mais , Precursor de Proteína beta-Amiloide/análise , Córtex Cerebral/patologia , Desmina/análise , Feminino , Humanos , Masculino , Microscopia Imunoeletrônica , Músculo Liso Vascular/ultraestrutura , Tropomiosina/análiseRESUMO
We examined vascular amyloid-beta deposition and other abnormalities in the posterior cerebral artery of consecutive cases of Alzheimer's disease (AD) compared to controls. Smooth muscle atrophy was a consistent feature in the cases of AD examined (p<0.01) and was surprisingly independent of adjacent amyloid-beta deposition. These findings suggest that vascular abnormalities are a consistent feature in AD and may be an important contributor to the pathogenesis and complications of AD.
Assuntos
Doença de Alzheimer/patologia , Artérias Cerebrais/patologia , Transtornos Cerebrovasculares/patologia , Atrofia Muscular/patologia , Lobo Occipital/irrigação sanguínea , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/etiologia , Doença de Alzheimer/metabolismo , Análise de Variância , Estudos de Casos e Controles , Artérias Cerebrais/metabolismo , Transtornos Cerebrovasculares/complicações , Transtornos Cerebrovasculares/metabolismo , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Atrofia Muscular/complicações , Atrofia Muscular/metabolismoRESUMO
The mitochondrial 4977-bp common deletion has been reported in some studies to occur exclusively or with increased frequency in the midbrain of patients with Parkinson's disease (PD). Other studies could not confirm these results; rather, it was suggested that the mitochondrial common deletion is associated with aging in the midbrain and not PD. One possible explanation for these conflicting results is the difficulty in quantifying mitochondrial DNA deletions or mutations in the whole midbrain or substantia nigra (SN) while only a subset of midbrain neurons degenerate in PD. In addition, none of the studies has addressed the cell types with the common deletion within the midbrain. In this study we used in situ hybridization to detect the common deletion in sections of midbrain from patients with PD, multiple system atrophy-parkinsonian type (MSA-P), progressive supranuclear palsy (PSP), dementia with Lewy bodies (DLB), age-matched controls, and individuals of different ages. The results demonstrated that the mitochondrial common deletion accumulated primarily in neurons but not glia in both the SN and other midbrain regions. There was no significant difference in the number or distribution of neurons with the common deletion or the average of the mean densities (AMD) of staining with the common deletion in nigral neurons among patients with PD, MSA-P, PSP, DLB, or age-matched controls. In addition, there was no difference in the number or distribution of neurons with the common deletion in nigral neurons between any age group, although there was a tendency for the common deletion to increase in the non-nigral neurons in older patients. These data indicate that accumulation of the 4977-bp common deletion in mitochondrial DNA in midbrain occurred primarily in neurons, and by this cytological approach, it was not associated with nigral neurodegeneration in the common movement disorders or aging.
Assuntos
DNA Mitocondrial/genética , Deleção de Genes , Transtornos dos Movimentos/genética , Doenças Neurodegenerativas/genética , Doença de Parkinson/genética , Adolescente , Adulto , Idoso , Envelhecimento/genética , Cadáver , Criança , Humanos , Hibridização In Situ , Mesencéfalo/fisiopatologia , Pessoa de Meia-IdadeAssuntos
Doença de Alzheimer/patologia , Precursor de Proteína beta-Amiloide/genética , Animais Geneticamente Modificados/genética , Encéfalo/metabolismo , Precursor de Proteína beta-Amiloide/biossíntese , Animais , Química Encefálica/genética , Química Encefálica/fisiologia , Humanos , Camundongos , Camundongos TransgênicosRESUMO
Oxidative damage of biological macromolecules is a hallmark of most neurodegenerative disorders such as Alzheimer, Parkinson and diffuse Lewy body diseases. Another important phenomenon involved in these disorders is the alteration of iron and copper homeostasis. Data from the literature support the involvement of metal homeostasis in mitochondrial dysfunction, protein alterations and nucleic acid damage which are relevant in brain function and consequently, in the development of neurodegenerative disorders. Although alterations in transition metal homeostasis, redox activity, and localization are well documented, it must be determined how alterations of specific copper- and iron-containing metalloenzymes are also involved in Alzheimer disease. The clarification of these phenomena can open a new window for understanding the mechanisms underlying neurodegeneration and, consequently, for the development of new therapeutic strategies such as gene therapy and new pharmaceutical formulations with antioxidant and chelating properties.
Assuntos
Doença de Alzheimer/etiologia , Doença de Alzheimer/fisiopatologia , Estresse Oxidativo/fisiologia , Animais , Cobre/metabolismo , Humanos , Ferro/metabolismo , OxirreduçãoRESUMO
The presence of dystrophic neurites in most extracellular neurofibrillary tangles (E-NFT) suggests a factor promoting neurite growth in E-NFT. Although the beta-protein detected in E-NFT may fill that role, reports that only 2-10% of E-NFT contain beta-protein whereas 80-100% contain dystrophic neurites suggested that beta-protein does not play an important role. In this study, the authors used two antisera and one monoclonal antibody to beta-protein to establish the effects of tissue preparation and formic acid enhancement on the detection of beta-protein in E-NFT. We found that beta-protein epitopes in E-NFT are sensitive to formaldehyde fixation and are best enhanced by 50% formic acid, whereas beta-protein in senile plaques is best enhanced at higher formic acid concentrations. After treatment with 50% formic acid, beta-protein was found in all E-NFT. Interestingly, after treatment with 10% formic acid, half of intraneuronal-NFT (I-NFT) also contained beta-protein immunoreactivity. The finding that beta-protein immunoreactivity in senile plaques, E-NFT and I-NFT is increased at different formic acid concentrations suggests that beta-protein in each location is in a different conformation. In contrast, no beta-protein immunoreactivity could be found in E-NFT of the brain stem, an area in which dystrophic neurites do not infiltrate E-NFT. These findings indicate a correlation between neuritic infiltration and presence of beta-protein in E-NFT and suggests the two are linked in Alzheimer's disease for E-NFT as well as senile plaques.